InspireMD (Nasdaq:NSPR) announced today that it appointed Dr. Peter A. Soukas as its new chief medical officer.
InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M.D ...
Explore how brain stenting can prevent strokes and the importance of early detection and lifestyle changes on World Stroke ...
UB neurosurgeon Elad Levy says the case proves complex endovascular procedures can be performed in outpatient neurosurgery ...
Medpace Holdings Inc (($MEDP)) announced an update on their ongoing clinical study. Study Overview: The SKYWARD Trans-Carotid IDE Study, ...
InspireMD Inc (($NSPR)) announced an update on their ongoing clinical study. Study Overview: InspireMD Inc. is conducting a pivotal study titled A ...
Dr. Kenneth Rosenfield discusses proficiencies required for performing transfemoral carotid artery stenting and how best to ...
What physicians need to know about the expanded carotid artery stenting coverage, including choice of therapy, shared ...
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on ...
The neurosurgeons say this marks a paradigm shift in how complex neurovascular interventions can safely be delivered.
The neurosurgeons say this marks a paradigm shift in how complex neurovascular interventions can safely be delivered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback